Javascript must be enabled to continue!
Sinai SCENT TMC - Human Colonoscopy Tissue Collection v1
View through CrossRef
For this study we will utilize the world-renowned Inflammatory Bowel Disease program at MSSM, started by Dr. Burrill B. Crohn in the Division of Gastroenterology. Eminent physicians, surgeons, radiologists, hepatologists, and pathologists have provided a rich body of knowledge in the diagnosis and management of inflammatory bowel disease, peptic ulcer disease, esophageal disorders, gastrointestinal cancer, and liver, biliary, pancreatic diseases, and Crohn’s Disease. Mount Sinai has been on the forefront of research, identification, and treatment of gastrointestinal illness since the division's early days. An outpatient clinic was founded and devoted solely to GI diseases in 1913. Today, Mount Sinai gastroenterologists care for more patients with inflammatory bowel disease (IBD) than any medical center in the country. Gastroenterologists from throughout the New York tristate area send their most challenging cases to our IBD physicians. This study will be one of many, on-going collaborations with faculty and staff from several groups involved with IBD research and clinical care throughout the Mount Sinai Medical Centers. In addition, the Mount Sinai Health System now has affiliated sites that are directly involved in the care of IBD patients seen at Mount Sinai Health System affiliated clinics and offices. These include the endoscopy centers at Beth Israel, Mount Sinai West, Mount Sinai St. Luke’s, and Carnegie Hill Endoscopy. Participants will be patients recruited from one of the largest gastroenterological outpatient clinic in the city.
Title: Sinai SCENT TMC - Human Colonoscopy Tissue Collection v1
Description:
For this study we will utilize the world-renowned Inflammatory Bowel Disease program at MSSM, started by Dr.
Burrill B.
Crohn in the Division of Gastroenterology.
Eminent physicians, surgeons, radiologists, hepatologists, and pathologists have provided a rich body of knowledge in the diagnosis and management of inflammatory bowel disease, peptic ulcer disease, esophageal disorders, gastrointestinal cancer, and liver, biliary, pancreatic diseases, and Crohn’s Disease.
Mount Sinai has been on the forefront of research, identification, and treatment of gastrointestinal illness since the division's early days.
An outpatient clinic was founded and devoted solely to GI diseases in 1913.
Today, Mount Sinai gastroenterologists care for more patients with inflammatory bowel disease (IBD) than any medical center in the country.
Gastroenterologists from throughout the New York tristate area send their most challenging cases to our IBD physicians.
This study will be one of many, on-going collaborations with faculty and staff from several groups involved with IBD research and clinical care throughout the Mount Sinai Medical Centers.
In addition, the Mount Sinai Health System now has affiliated sites that are directly involved in the care of IBD patients seen at Mount Sinai Health System affiliated clinics and offices.
These include the endoscopy centers at Beth Israel, Mount Sinai West, Mount Sinai St.
Luke’s, and Carnegie Hill Endoscopy.
Participants will be patients recruited from one of the largest gastroenterological outpatient clinic in the city.
Related Results
1175 Ileal Carcinoid Tumors Detected During Screening versus Diagnostic Colonoscopy: Comparison of Tumor Characteristics
1175 Ileal Carcinoid Tumors Detected During Screening versus Diagnostic Colonoscopy: Comparison of Tumor Characteristics
INTRODUCTION:
Small intestinal carcinoid tumors are the most common type of small bowel malignancy observed. Most are indolent and incidentally found in asymptomatic pa...
Teaching old dogs and young dogs new tricks: canine scent detection for seabird monitoring
Teaching old dogs and young dogs new tricks: canine scent detection for seabird monitoring
Dogs Canis familiaris have been domesticated for over 11,000 years and have been trained to perform a vast array of tasks. Scent dogs are routinely used to detect elusive animals o...
Screening Colonoscopy Uptake Among Adult Stroke Survivors: Findings from the 2022 BRFSS Data
Screening Colonoscopy Uptake Among Adult Stroke Survivors: Findings from the 2022 BRFSS Data
Background/Objectives: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths globally. Screening for cancer helps to prevent comorbid conditions among indivi...
2843 Lack of Knowledge About Follow-Up Colonoscopy in Patients With Biopsy Proven Advanced Colorectal Polyps: A Major Clinical and Medicolegal Challenge
2843 Lack of Knowledge About Follow-Up Colonoscopy in Patients With Biopsy Proven Advanced Colorectal Polyps: A Major Clinical and Medicolegal Challenge
INTRODUCTION:
The most recent guidelines from the American College of Gastroenterology recommend that patients with biopsy proven advanced colorectal polyps undergo rep...
ARTIFICIAL INTELLIGENCE APPLICATION IN COLONOSCOPY SCREENING: A LITERATURE REVIEW
ARTIFICIAL INTELLIGENCE APPLICATION IN COLONOSCOPY SCREENING: A LITERATURE REVIEW
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally and remains a leading cause of cancer-related deaths. Despite the effectiveness of colonosc...
Ileal neuroendocrine tumors detected during screening or diagnostic colonoscopy – case series and comparison of tumor characteristics.
Ileal neuroendocrine tumors detected during screening or diagnostic colonoscopy – case series and comparison of tumor characteristics.
Abstract
Purpose: Small intestinal neuroendocrine tumors are the most common type of small bowel malignancy observed. Ileal tumors are often found in patients undergoing il...
Indications and Diagnostic Yield of Colonoscopy in Kano, Nigeria
Indications and Diagnostic Yield of Colonoscopy in Kano, Nigeria
Context:
Colonoscopy is the investigation of choice for colonic lesions and has been widely used to diagnose and treat various colonic diseases. As essential as it is, ...

